Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 58

1.

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.

Jensen AD, Nikoghosyan AV, Lossner K, Herfarth KK, Debus J, Münter MW.

BMC Cancer. 2012 May 2;12:163. doi: 10.1186/1471-2407-12-163.

PMID:
22551422
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.

Jensen AD, Krauss J, Potthoff K, Simon C, Nikoghosyan AV, Lossner K, Debus J, Münter MW.

Radiat Oncol. 2012 Apr 2;7:57. doi: 10.1186/1748-717X-7-57.

PMID:
22472064
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT.

Jensen AD, Winter M, Kuhn SP, Debus J, Nairz O, Münter MW.

Radiat Oncol. 2012 Mar 29;7:51. doi: 10.1186/1748-717X-7-51.

PMID:
22458824
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Herfarth KK, Münter MW.

Radiat Oncol. 2011 Nov 2;6:149. doi: 10.1186/1748-717X-6-149.

PMID:
22046954
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Jensen AD, Krauss J, Weichert W, Bergmann ZP, Freier K, Debus J, Münter MW.

Radiat Oncol. 2011 Sep 23;6:122. doi: 10.1186/1748-717X-6-122.

PMID:
21942981
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Assessment of peri- and postoperative complications and Karnofsky-performance status in head and neck cancer patients after radiation or chemoradiation that underwent surgery with regional or free-flap reconstruction for salvage, palliation, or to improve function.

Simon C, Bulut C, Federspil PA, Münter MW, Lindel K, Bergmann Z, Sertel S, Leitzbach S, Plinkert PK.

Radiat Oncol. 2011 Sep 6;6:109. doi: 10.1186/1748-717X-6-109.

PMID:
21896171
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PC.

Nikoghosyan AV, Schulz-Ertner D, Herfarth K, Didinger B, Münter MW, Jensen AD, Jäkel O, Hoess A, Haberer T, Debus J.

Acta Oncol. 2011 Aug;50(6):784-90. doi: 10.3109/0284186X.2011.584558.

PMID:
21767175
[PubMed - indexed for MEDLINE]
8.

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.

Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jäger D, Münter MW.

BMC Cancer. 2011 Jun 24;11:266. doi: 10.1186/1471-2407-11-266.

PMID:
21702914
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Re-irradiation with scanned charged particle beams in recurrent tumours of the head and neck: acute toxicity and feasibility.

Jensen AD, Nikoghosyan A, Ellerbrock M, Ecker S, Debus J, Münter MW.

Radiother Oncol. 2011 Dec;101(3):383-7. doi: 10.1016/j.radonc.2011.05.017. Epub 2011 Jun 2.

PMID:
21640421
[PubMed - indexed for MEDLINE]
10.

Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12).

Jensen AD, Nikoghosyan AV, Windemuth-Kieselbach C, Debus J, Münter MW.

BMC Cancer. 2011 May 22;11:190. doi: 10.1186/1471-2407-11-190.

PMID:
21600049
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HIT.

Jensen AD, Krauss J, Potthoff K, Desta A, Habl G, Mavtratzas A, Windemuth-Kiesselbach C, Debus J, Münter MW.

BMC Cancer. 2011 May 19;11:182. doi: 10.1186/1471-2407-11-182.

PMID:
21595970
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Münter MW.

Radiat Oncol. 2011 Apr 5;6:30. doi: 10.1186/1748-717X-6-30.

PMID:
21466696
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Review of clinical experience with ion beam radiotherapy.

Jensen AD, Münter MW, Debus J.

Br J Radiol. 2011 Dec;84 Spec No 1:S35-47. doi: 10.1259/bjr/71511359. Epub 2011 Mar 22. Review.

PMID:
21427183
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].

Jensen AD, Nikoghosyan A, Hinke A, Debus J, Münter MW.

BMC Cancer. 2011 Feb 15;11:70. doi: 10.1186/1471-2407-11-70.

PMID:
21320355
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer.

Jensen AD, Nill S, Huber PE, Bendl R, Debus J, Münter MW.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):590-6. doi: 10.1016/j.ijrobp.2010.10.072. Epub 2011 Feb 8.

PMID:
21310549
[PubMed - indexed for MEDLINE]
16.

Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.

Rieken S, Habermehl D, Nikoghosyan A, Jensen A, Haberer T, Jäkel O, Münter MW, Welzel T, Debus J, Combs SE.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e793-801. doi: 10.1016/j.ijrobp.2010.12.018. Epub 2011 Feb 6.

PMID:
21300464
[PubMed - indexed for MEDLINE]
17.

Carbon ion therapy for ameloblastic carcinoma.

Jensen AD, Ecker S, Ellerbrock M, Nikoghosyan A, Debus J, Münter MW.

Radiat Oncol. 2011 Feb 6;6:13. doi: 10.1186/1748-717X-6-13.

PMID:
21294917
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancer.

Zwicker F, Roeder F, Hauswald H, Thieke C, Timke C, Schlegel W, Debus J, Münter MW, Huber PE.

Head Neck. 2011 Dec;33(12):1695-702. doi: 10.1002/hed.21663. Epub 2011 Jan 31.

PMID:
21284054
[PubMed - indexed for MEDLINE]
19.

Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial.

Jensen AD, Münter MW, Bischoff HG, Haselmann R, Haberkorn U, Huber PE, Thomas M, Debus J, Herfarth KK.

Cancer. 2011 Jul 1;117(13):2986-94. doi: 10.1002/cncr.25888. Epub 2011 Jan 24.

PMID:
21264838
[PubMed - indexed for MEDLINE]
Free Article
20.

IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer.

Zwicker F, Roeder F, Thieke C, Timke C, Münter MW, Huber PE, Debus J.

Strahlenther Onkol. 2011 Jan;187(1):32-8. doi: 10.1007/s00066-010-2149-7. Epub 2010 Dec 23.

PMID:
21234529
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk